Developing a culturally tailored mHealth symptom monitoring intervention to improve adherence to endocrine therapy among Black women with breast cancer

开发适合文化的移动健康症状监测干预措施，以提高患有乳腺癌的黑人女性对内分泌治疗的依从性

• 批准号: 10642274
• 负责人: Kimberley T Lee
• 金额: $ 28.46万
• 依托单位: H. LEE MOFFITT CANCER CTR & RES INST
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-18 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10642274
• 关键词: Address; Adherence; Behavior Therapy; Biological; Black Populations; Black race; Breast Cancer survivor; Cancer Center; Cancer Survivor; Cancer Survivorship; Caring; Cessation of life; Clinical; Clinical Research; Comprehension; Consent; Control Groups; Data; Daughter; Department chair; Development; Development Plans; Discipline; Disparity; Educational Materials; Educational workshop; Eligibility Determination; Encapsulated; Ensure; Environment; Epidemiologic Methods; Epidemiology; Feedback; Foundations; Funding; Future; Goals; Health Technology; High Risk Woman; Institution; Intervention; Interview; Life; Malignant Neoplasms; Measures; Mentorship; Methods; Minority; Modeling; Monitor; Observational epidemiology; Oncology; Outcome; Participant; Pathway interactions; Patients; Pharmaceutical Preparations; Phase; Pilot Projects; Population; Population Sciences; Positioning Attribute; Preparation; Provider; Publishing; Qualitative Methods; Quality of life; Randomized; Randomized, Controlled Trials; Recording of previous events; Recurrence; Recurrent Malignant Neoplasm; Reporting; Research; Resources; Risk Reduction; Scientist; Solid; Specimen; Structure; Survival Rate; Symptoms; Technology; Testing; Training; Treatment Efficacy; Trust; Vulnerable Populations; Woman; Work; adjuvant endocrine therapy; behavior test; behavioral clinical trial; black patient; black women; cancer care; cancer diagnosis; cancer health disparity; cancer recurrence; candidate identification; care delivery; career; career development; comparative efficacy; disparity reduction; efficacy evaluation; efficacy trial; experience; health care disparity; health disparity populations; hormone receptor-positive; hormone therapy; improved; innovation; intervention participants; intervention refinement; mHealth; mHealth methodology; malignant breast neoplasm; medication compliance; pilot test; programs; racial diversity; racism; randomized trial; randomized, clinical trials; recruit; skills; social cognitive theory; survival disparity; symposium; symptom management; tailored messaging; theories; therapy adherence; therapy development; treatment as usual; urinary

PROJECT SUMMARY Candidate Goals. My career goal is to reduce breast cancer health disparities in outcomes by addressing cancer care delivery issues in minority cancer populations. I received a solid foundation in observational epidemiological methods which I have applied to cancer survivorship research, but my training has not provided the skills I need to develop mHealth behavioral interventions or culturally-tailor and test behavioral interventions. The K08 provides an ideal opportunity to develop the necessary skills to achieve my long-term career goal as an independent clinical scientist. Candidate Career Development Plan. In this application, I propose training to develop the skills necessary to become a leader in the field of developing mHealth behavioral interventions for medication adherence and other cancer care delivery issues in minority cancer survivors. Training will be obtained through participation in scientific conferences, methods workshop, coursework, and structed mentorship from experts in developing culturally tailored behavioral interventions (Dr. Clement Gwede), adherence to endocrine therapy among patients with breast cancer (Dr. Dawn Hershman), mHealth methodology (Dr. Brian Gonzalez), randomized clinical trials of behavioral interventions (Dr. Heather Jim), recruitment and retention of minority participants to clinical studies (Dr. Susan Vadaparampil), and Biospecimen quality and testing (Dr. Shelley Tworoger). This training will ensure that I achieve my short-term goals after which I will be uniquely positioned to bridge gaps across disciplines, including: 1) Clinical breast cancer care, 2) Behavioral intervention development, cultural tailoring, and testing, and 3) Using mobile health technologies and biologic specimens in studies among vulnerable populations. Institutional Environment. The research environment, facilities, and resources at Moffitt Cancer Center are ideal for career development and I have the full support of my Department Chair, Dr. Czerniecki and Associate Center Director of the Division of Population Sciences, Dr. Shelley Tworoger. Research Plan. We propose an iterative approach to develop and pilot test a new mHealth behavioral intervention for AET adherence that is culturally tailored to Black breast cancer survivors. We will first use qualitative methods informed by Black breast cancer survivors to develop a blueprint of the intervention (Aim 1). We will then iteratively refine and culturally tailor the mHealth intervention focusing on symptom monitoring and management (Aim 2). Lastly, we will test the intervention for acceptability, feasibility, and preliminary efficacy (Aim 3). This project will address quality of life (symptom burden) and care delivery (medication adherence) issues in a health disparity population.

项目总结 候选人目标。我的职业目标是通过解决以下问题来减少乳腺癌健康状况的差异 少数癌症人群中的癌症护理提供问题。我在观察学方面获得了坚实的基础 我曾将流行病学方法应用于癌症生存研究，但我的培训还没有 提供我开发mHealth行为干预或文化定制和测试行为所需的技能 干预措施。K08提供了一个理想的机会来发展必要的技能，以实现我的长期 职业目标是成为一名独立的临床科学家。 应聘者职业发展计划。在此应用程序中，我建议进行培训以发展必要的技能 成为开发mHealth行为干预药物依从性和 少数癌症幸存者的其他癌症护理服务问题。培训将通过参与以下活动获得 科学会议、方法研讨会、课程作业和来自开发专家的结构化指导 文化定制的行为干预(克莱门特·格韦德博士)，坚持内分泌治疗 乳腺癌患者(Dawn Hershman博士)，mHealth方法论(Brian Gonzalez博士)，随机 行为干预的临床试验(希瑟·吉姆博士)，招募和保留少数群体参与者以 临床研究(Susan Vada arampil博士)和生物菌素质量和检测(Shelley Tworoger博士)。这 培训将确保我实现我的短期目标，之后我将处于独特的位置来弥合差距 跨学科，包括：1)临床乳腺癌护理，2)行为干预发展，文化 定制和测试，以及3)在以下研究中使用移动卫生技术和生物标本 弱势群体。 制度环境。莫菲特癌症中心的研究环境、设施和资源是 非常适合职业发展，我得到了我的系主任切尔尼茨基博士和助理的全力支持 人口科学部中心主任雪莱·特沃罗格博士。 研究计划。我们提出了一种迭代方法来开发和试点测试新的mHealth行为 为黑人乳腺癌幸存者量身定做的AET依从性干预。我们将首先使用 定性方法了解黑人乳腺癌幸存者制定干预蓝图(目的 1)。然后，我们将反复改进并在文化上定制侧重于症状监控的mHealth干预 和管理(目标2)。最后，我们将测试干预措施的可接受性、可行性和初步 功效(目标3)。该项目将解决生活质量(症状负担)和护理提供(药物治疗 坚持)健康差距人口中的问题。